Thursday, 1 August 2013

Market Overview: Global and China Blood Product Market Forecast 2013-2017


Description

Blood products are made by separating and extracting various proteins in plasma and classified into albumin products, immune globulin products, coagulation factor products and other blood products. China enterprises mainly produce nine kinds of products of the first three categories.




The concentration rate of global blood products is very high and the 5 enterprises of developed countries occupy 8085% of the market. The global plasma volume in 2012 exceeded 30,000 tons and the market scale reached USD 17.5 billion, increasing by 7.4% YOY. The current global blood product market remains relatively stable, mainly driven by emerging economies. 

There are strict regulations and high barriers to entry in China blood product industry. No new blood product manufacturing enterprises are allowed to be further established and the import of most blood product varieties is limited. By July 2013, there are only about 20 blood product manufacturers with normal production in China, with small annual plasma volumes and a low market concentration rate. 


To Buy The Copy of This Report Visit : http://www.marketresearchreports.biz/analysis/172379   


Table of Content

Chapter 1 Introduction of Blood Products
1.1 Definition
1.2 Classification
1.2.1 Albumin
1.2.2 Immune Globulin
1.2.3 Coagulation Factors
1.2.4 Other Categories
1.3 Characteristics of Blood Products

Chapter 2 Overview on Global Blood Product Industry, 2008-2012
2.1 Industry Overview
2.1.1 Development Process
2.1.2 Competition Pattern
2.1.3 Supply Status
2.1.4 Demand Status
2.2 Major Blood Product Manufacturers in the Globe
2.2.1 Baxter International
2.2.2 CSL Behring
2.2.3 Grifols SA


Contact

M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948

No comments:

Post a Comment